Lisa Keith
Nurse Practitioner · Colorado Springs, CONPI 1194776013
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $48,594 of the $52,089 with a category attached, or 93.3%. Medtronic accounts for 97.6% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $21,101, more than ten times the $715 reported in 2021. Among nurse practitioner clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 169 payments — averaging $308.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$51K
- Tandem Diabetes Care, Inc.$250
- Abbott$231
- Dexcom, Inc.$219
- Insulet Corporation$156
- Sanofi-aventis U.S. LLC$133
- plus $246 from 7 others
What the payments were for
- Speaking & faculty fees$48,59493%
- Travel & lodging$1,2302%
- Food & beverage$2,2654%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 139 | $50,854 |
| Tandem Diabetes Care, Inc. | 6 | $250 |
| Abbott | 3 | $231 |
| Dexcom, Inc. | 4 | $219 |
| Insulet Corporation | 3 | $156 |
| Sanofi-aventis U.S. LLC | 3 | $133 |
| Sequel Med Tech, LLC | 2 | $84 |
| Xeris Pharmaceuticals, Inc. | 3 | $66 |
| Lilly USA, LLC | 1 | $30 |
| Novo Nordisk | 1 | $18 |
| BETA Bionics, Inc. | 2 | $18 |
| AstraZeneca | 1 | $16 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$45,164
- MINIMED 770G$3,637
- InPen$515
- FreeStyle Libre$194
- DEXCOM G7 GSS (161)$149
- t:slim X2 Insulin Pump with Control-IQ$132
How this compares
$52,089 in reported general payments places this provider in the 95th percentile of 1,384 nurse practitioner providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 190 | $245,953 |
| OzempicSemaglutide | 141 | $213,047 |
| JardianceEmpagliflozin | 157 | $190,095 |
| TrulicityDulaglutide | 113 | $170,783 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 54 | $64,694 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 43 | $41,343 |
| Tresiba Flextouch U-100Insulin Degludec | 43 | $38,791 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $28,310 |
| FarxigaDapagliflozin Propanediol | 32 | $27,288 |
| HumalogInsulin Lispro | 46 | $19,604 |
| Humalog Kwikpen U-100Insulin Lispro | 69 | $18,019 |
| BaqsimiGlucagon | 50 | $17,357 |
| Novolog FlexpenInsulin Aspart | 48 | $17,115 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 20 | $15,553 |
| Tresiba Flextouch U-200Insulin Degludec | 19 | $14,872 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Baqsimi, Insulin Lispro | $30 | $457,876431 claims |
| Novo NordiskOzempic, Novolog | $18 | $219,671175 claims |
| AstraZenecaFarxiga | $16 | $27,28832 claims |
| Sanofi-aventis U.S. LLCLantus | $133 | $3,22113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,384 nurse practitioner providers in Colorado.
Other nurse practitioner in Colorado Springs
- Deborah HinnenColorado Springs$388K
- Brianne WagnerColorado Springs$11K
- Morgan TevlinColorado Springs$9K
- Jill SmothersColorado Springs$8K
- Tracey PutzColorado Springs$8K
- Chris SchabingerColorado Springs$7K
- Bridget CoyneColorado Springs$6K
- Anne ZobecColorado Springs$5K
- Kathryn BlairColorado Springs$5K
- Mary Burkhart-GordonColorado Springs$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.